Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Payne

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
BJU International|March 22, 2021
How reliable are surgeon-reported data? A comparison of the British Association of Urological Surgeons radical prostatectomy audit with the National Prostate Cancer Audit Hospital Episode Statistics-linked databaseJonathan J Aning, Matthew G Parry, Jan van der Meulen, et al.
Urology|May 24, 2021
SpaceOAR Hydrogel Spacer for Reducing Radiation Toxicity During Radiotherapy for Prostate Cancer. A Systematic ReviewNigel Armstrong, Amit Bahl, Michael Pinkawa, et al.
Clinical Genitourinary Cancer|December 17, 2014
Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK PracticeWei Shen Tan, Benjamin W Lamb, Heather Payne, et al.
BJU International|September 16, 2010
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trialNicholas D James, Armelle Caty, Heather Payne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Treatment-Related Toxicity Using Prostate-Only Versus Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy: A National Population-Based StudyMatthew G Parry, Arunan Sujenthiran, Thomas E Cowling, et al.
Cancer Epidemiology|November 22, 2018
Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptionsMatthew G Parry, Arunan Sujenthiran, Thomas E Cowling, et al.
European Urology|January 17, 2017
Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric OncologyJean-Pierre Droz, Gilles Albrand, Silke Gillessen, et al.
International Journal of Cancer|December 15, 2018
Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in EnglandMatthew G Parry, Arunan Sujenthiran, Thomas E Cowling, et al.
BJU International|September 5, 2013
Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challengesHeather Payne, Andrew Adamson, Amit Bahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 19, 2018
Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based studyArunan Sujenthiran, Julie Nossiter, Matthew Parry, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
BJU International|March 22, 2021
How reliable are surgeon-reported data? A comparison of the British Association of Urological Surgeons radical prostatectomy audit with the National Prostate Cancer Audit Hospital Episode Statistics-linked databaseJonathan J Aning, Matthew G Parry, Jan van der Meulen, et al.
Urology|May 24, 2021
SpaceOAR Hydrogel Spacer for Reducing Radiation Toxicity During Radiotherapy for Prostate Cancer. A Systematic ReviewNigel Armstrong, Amit Bahl, Michael Pinkawa, et al.
Clinical Genitourinary Cancer|December 17, 2014
Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK PracticeWei Shen Tan, Benjamin W Lamb, Heather Payne, et al.
BJU International|September 16, 2010
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-blind, placebo-controlled, randomized Phase II trialNicholas D James, Armelle Caty, Heather Payne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2019
Treatment-Related Toxicity Using Prostate-Only Versus Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy: A National Population-Based StudyMatthew G Parry, Arunan Sujenthiran, Thomas E Cowling, et al.
Cancer Epidemiology|November 22, 2018
Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptionsMatthew G Parry, Arunan Sujenthiran, Thomas E Cowling, et al.
European Urology|January 17, 2017
Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric OncologyJean-Pierre Droz, Gilles Albrand, Silke Gillessen, et al.
International Journal of Cancer|December 15, 2018
Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in EnglandMatthew G Parry, Arunan Sujenthiran, Thomas E Cowling, et al.
BJU International|September 5, 2013
Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challengesHeather Payne, Andrew Adamson, Amit Bahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 19, 2018
Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based studyArunan Sujenthiran, Julie Nossiter, Matthew Parry, et al.
Pageof 12